FDA Inspection 1269309 — Precigen Inc
The FDA completed an inspection of Precigen Inc on Apr 15, 2025 in Germantown, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 15, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Germantown, MD (United States)
Additional details
Sponsor, Contract Research Organization